Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
NCT03546192
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Fluzone Quadrivalent Influenza Vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company